Nearly one year after marijuana was legalized in New Jersey and officials are still mum on when adults 21 years or older will be able to purchase legal weed — and one key group of stakeholders is losing patience. New Jersey medical marijuana operators are chomping at the bit... Read more
By Scott Thomas Designing a security solution for your cannabis business can feel complex and overwhelming. There are a lot of considerations: cost, of course, but also scalability, versatility, resiliency, cybersecurity, and more. Not only do you need to protect your facility and the people and products within it,... Read more
Her 17-year-old son looked like he was dying. Angie Calhoun could hardly bear to watch her only child, Austin Calhoun, go from active and happy to bedridden and miserable, as he began experiencing focal seizures, severe joint pain, and chronic nausea and vomiting. The debilitating medical conditions took their... Read more
Her 17-year-old son looked like he was dying. Angie Calhoun could hardly bear to watch her only child, Austin Calhoun, go from active and happy to bedridden and miserable, as he began experiencing focal seizures, severe joint pain, and chronic nausea and vomiting. The debilitating medical conditions took their... Read more
Her 17-year-old son looked like he was dying. Angie Calhoun could hardly bear to watch her only child, Austin Calhoun, go from active and happy to bedridden and miserable, as he began experiencing focal seizures, severe joint pain, and chronic nausea and vomiting. The debilitating medical conditions took their... Read more
Ryan Allway January 11th, 2022 Psychedelics Company poised for rapid expansion in 2022 after highly successful 2021, in which it secured commercial deployments across three continents, US FDA registration and multiple awards for innovation in AI VANCOUVER, BC, Jan. 11, 2022 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE:... Read more
Ryan Allway January 11th, 2022 Psychedelics TEL AVIV, Israel, Jan. 11, 2022 /PRNewswire/ — SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company”), announced that it has begun to examine the possibility of including psychedelic... Read more
The registration of cannabis trademarks in the United States raises novel issues. This is an unsurprising result of the uneasy coexistence between expanding legality at the state level, and ongoing prohibition at the federal level. Cannabis businesses need to keep these issues on their radar when crafting brand strategies. At the same time, however, they
On January 4, 2022, amendments to Health Canada’s Special Access Program took effect that explicitly include access to psychedelic medicine. We asked Numinus’ Payton Nyquvest to connect the dots on the impact of these new rules.
